Search Results 251-260 of 16029 for SC

  1. Publications - Yajue Huang, M.D., Ph.D. - Mayo Clinic

    ... SC, Stathias V, Chen XS, Barcellos-Hoff MH, Starr TK, Winterhoff BJ, Nelson AC, Mok SC, Kaufmann SH, Drescher C, Cieslik M, Wang P, Birrer MJ, Paulovich AG.

  2. Mallory J. Raymond, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina. Since joining Mayo Clinic Florida in 2022, Dr. Raymond has been actively involved in the education of medical students and residents. Her ...

  3. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    ... (SC) injection every 4th week in patients with relapsing or refractory EGPA on corticosteroid therapy with or without stable immunosuppressive therapy. All ...

  4. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  5. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research

    Camilleri, Michael M.D., D.Sc. camilleri.michael@mayo.edu; Professor of Medicine; Professor of Pharmacology; Professor of Physiology; Publications · Chini ...

  6. Publications - Caroline J. Davidge-Pitts, M.B., B.Ch. - Mayo Clinic

    2025. Engstrom K, Bellolio F, Jeffery MM, Sutherland SC, Carpenter KP, Jackson G, Cole K, Chedid V, Davidge-Pitts CJ, Sunga KL, Gonzalez C, Brown CS.

  7. Melanoma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...

  8. Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW ...

  9. Schizoaffective disorder - Symptoms and causes - Mayo Clinic

    This mental health condition includes schizophrenia symptoms, such as delusions and hallucinations, and mood disorder symptoms, such as depression and ...

  10. Roberto P. Benzo, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    Fellow - Pulmonary and Critical Care MedicineMedical University of South Carolina. 1996. Resident - Internal MedicineMedical University of South Carolina. 1995.